CASP3 and prostate cancer: induced a significant dose-dependent decrease in the cell viability.inhibited prostate cancer cell proliferation by inhibiting the cell cycle in the G0/G1 phase.induced apoptosis by releasing cytochrome c, caspase-3, and poly ADP-ribose polymerase.